Trust tied to TransDigm (NYSE: TDG) director sells and exercises 10K shares
Rhea-AI Filing Summary
TransDigm Group Inc. director W. Nicholas Howley, through the W. Nicholas Howley Family Trust u/a/d 4/23/99, reported an exercise-and-sell sequence in TransDigm common stock. The trust exercised stock options for 10,132 shares at exercise prices of $66.47 and $50.92 per share.
On the same date, the trust completed multiple open-market sales totaling 10,132 shares at per-share prices generally around $1,260–$1,272, reported as weighted averages for several price ranges. Following these transactions, the trust indirectly held 21,547.513 shares of TransDigm common stock.
Positive
- None.
Negative
- None.
Insights
Trust tied to a TransDigm director exercised options and sold an offsetting share amount in routine open-market trades.
The filing shows the W. Nicholas Howley Family Trust exercised stock options for 10,132 TransDigm shares at strike prices of $66.47 and $50.92. These exercises convert low-cost option awards into common stock, eliminating the related derivative position shown in this report.
The trust then executed open-market sales of 10,132 shares at weighted-average prices in several bands between roughly $1,260 and $1,272. After these transactions, it still indirectly holds 31,336.513 shares, indicating a remaining substantial equity position. No Rule 10b5-1 trading plan is referenced in the provided data.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,132 shares ($12.30M approx. pre-tax spread)
Exercise and Sale
15 txns
Insider
Howley W Nicholas
Role
Director
Sold
10,132 shs ($12.82M)
Approx. gross sale proceeds
$12.82M
Approx. exercise cost
$521K
Approx. pre-tax spread
$12.30M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 9,789 | $0.00 | $0.00 |
| Exercise | Stock Option | 343 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,789 | $50.92 | $498K |
| Exercise | Common Stock | 343 | $66.47 | $23K |
| Sale | Common Stock | 60 | $1,260.3385 | $76K |
| Sale | Common Stock | 1,035 | $1,261.6428 | $1.31M |
| Sale | Common Stock | 3,077 | $1,262.6557 | $3.89M |
| Sale | Common Stock | 589 | $1,263.811 | $744K |
| Sale | Common Stock | 694 | $1,264.9493 | $878K |
| Sale | Common Stock | 1,304 | $1,266.133 | $1.65M |
| Sale | Common Stock | 1,673 | $1,267.1369 | $2.12M |
| Sale | Common Stock | 940 | $1,268.4574 | $1.19M |
| Sale | Common Stock | 270 | $1,269.6204 | $343K |
| Sale | Common Stock | 430 | $1,270.4586 | $546K |
| Sale | Common Stock | 60 | $1,271.63 | $76K |
Holdings After Transaction:
Stock Option — 42,228 shares (Indirect, W. Nicholas Howley Family Trust u/a/d 4/23/99);
Common Stock — 21,547.513 shares (Indirect, W. Nicholas Howley Family Trust u/a/d 4/23/99)
Footnotes (11)
- F1. The exercise price has been adjusted for dividends declared since August 1, 2022.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,260.0000 - $1,260.4800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,261.1800 - $1,262.1200. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,262.2500 - $1,263.1700. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,263.3700 - $1,264.1000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,264.5500 - $1,265.5300. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,265.6650 - $1,266.6550. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,266.7200 - $1,267.6800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F9. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,267.7700 - $1,268.7600. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F10. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,268.9300 - $1,269.8800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F11. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,270.4000 - $1,270.4900. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Key Figures
Shares sold: 10,132 shares
Option exercises: 10,132 shares
Strike price 1: $66.47 per share
+4 more
7 metrics
Shares sold
10,132 shares
Total TransDigm common stock sold in open-market trades on 20 Apr 2026
Option exercises
10,132 shares
Underlying TransDigm shares acquired via stock option exercises on 20 Apr 2026
Strike price 1
$66.47 per share
Exercise price for 343 TransDigm option shares held by the trust
Strike price 2
$50.92 per share
Exercise price for 9,789 TransDigm option shares held by the trust
Sale price example
$1,271.63 per share
Weighted-average price for a 60-share TransDigm sale lot
Post-transaction holdings
31,336.513 shares
TransDigm common stock indirectly owned by the family trust after transactions
Remaining options
0 shares
Reported remaining shares under the 9,789-share option grant after exercise
Key Terms
open-market sale, Stock Option, exercise price, average weighted price, +2 more
6 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option financial
""security_title": "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"The exercise price has been adjusted for dividends declared"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
average weighted price financial
"Price reported constitutes the average weighted price of shares sold."
indirect financial
""ownership_type": "indirect""
derivative exercise/conversion financial
""transaction_action": "derivative exercise/conversion""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider activity did TransDigm (TDG) report in this Form 4?
The Form 4 reports that the W. Nicholas Howley Family Trust, associated with a TransDigm director, exercised stock options for 10,132 common shares and sold 10,132 shares in multiple open-market transactions, all dated 20 April 2026, leaving a significant remaining indirect shareholding.
How many TransDigm (TDG) stock options were exercised and at what strike prices?
The filing shows option exercises for 10,132 underlying TransDigm common shares. These came from two stock option grants: 343 shares at a strike price of $66.47 and 9,789 shares at a strike price of $50.92, both exercised by the family trust on 20 April 2026.
Were the TransDigm (TDG) insider sales part of open-market transactions?
Yes. Each sale transaction in the Form 4 is coded “S” and described as an open-market or private transaction, with weighted-average sale prices and detailed price ranges provided in the footnotes. No reference to a Rule 10b5-1 trading plan appears in the provided disclosures.
Does the Howley family trust retain any TransDigm (TDG) stock options after these exercises?
The derivative section shows two stock option positions exercised for 343 and 9,789 shares, with the larger grant reported at zero remaining following the transaction. The derivative summary is empty, indicating no additional option positions are reported in this particular filing excerpt.